We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.06%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.35B
AUM Growth
-$265M
(-5.7%)
Cap. Flow
-$308M
Cap. Flow
% of AUM
-7.08%
Top 10 Holdings %
Top 10 Hldgs %
16.54%
Holding
629
New
5
Increased
18
Reduced
506
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.19M |
| 2 |
Medtronic
MDT
|
+$6.17M |
| 3 |
Qorvo
QRVO
|
+$3.05M |
| 4 |
Alkermes
ALKS
|
+$3M |
| 5 |
Comcast
CMCSA
|
+$2.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$15M |
| 2 |
Apple
AAPL
|
+$12.4M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$11M |
| 4 |
ExxonMobil
XOM
|
+$5.57M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$4.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.89% |
| 2 | Technology | 15.07% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
HP
HPQ
$24.9B
| $13.1M | 0.3% |
923,763
-57,519
| -6% | -$949K |
|
77
DuPont de Nemours
DD
$18.5B
| $12.9M | 0.3% |
105,418
-9,510
| -8% | -$1.13M |
|
78
Occidental Petroleum
OXY
$56.8B
| $12.8M | 0.29% |
173,642
-13,893
| -7% | -$1.07M |
|
79
Ford
F
$58.5B
| $12.7M | 0.29% |
785,398
-56,231
| -7% | -$887K |
|
|
MON
80
DELISTED
Monsanto Co
MON
| $12.2M | 0.28% |
107,582
-20,141
| -16% | -$2.39M |
|
81
Duke Energy
DUK
$97.8B
| $12M | 0.28% |
156,714
-11,608
| -7% | -$942K |
|
82
Thermo Fisher Scientific
TMO
$213B
| $12M | 0.28% |
89,371
-5,668
| -6% | -$731K |
|
83
Danaher
DHR
$137B
| $11.8M | 0.27% |
206,886
-19,328
| -9% | -$1.11M |
|
|
EMC
84
DELISTED
EMC CORPORATION
EMC
| $11.7M | 0.27% |
457,394
-25,061
| -5% | -$690K |
|
85
Liberty Media Series C
FWONK
$24.6B
| $11.7M | 0.27% |
353,420
-14,216
| -4% | -$373K |
|
86
McKesson
MCK
$100B
| $11.7M | 0.27% |
51,793
-3,238
| -6% | -$718K |
|
87
Morgan Stanley
MS
$331B
| $11.5M | 0.27% |
323,537
-26,062
| -7% | -$935K |
|
88
EOG Resources
EOG
$79.2B
| $11.3M | 0.26% |
123,075
-7,168
| -6% | -$648K |
|
89
PNC Financial Services
PNC
$99.7B
| $11.1M | 0.25% |
118,858
-10,856
| -8% | -$980K |
|
90
Blackrock
BLK
$169B
| $11M | 0.25% |
29,964
-2,136
| -7% | -$774K |
|
|
KRFT
91
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $10.9M | 0.25% |
125,303
-15,578
| -11% | -$1.03M |
|
92
Target
TGT
$65.6B
| $10.9M | 0.25% |
132,808
-9,939
| -7% | -$768K |
|
93
TJX Companies
TJX
$174B
| $10.9M | 0.25% |
310,466
-22,488
| -7% | -$765K |
|
94
General Motors
GM
$80.4B
| $10.6M | 0.24% |
283,039
-17,344
| -6% | -$631K |
|
95
MetLife
MET
$61.9B
| $10.2M | 0.23% |
226,748
-14,592
| -6% | -$656K |
|
96
Caterpillar
CAT
$375B
| $10.2M | 0.23% |
127,438
-12,406
| -9% | -$1.03M |
|
97
NextEra Energy
NEE
$181B
| $10.2M | 0.23% |
390,668
-24,276
| -6% | -$640K |
|
|
BNY
98
Bank of New York Mellon
BNY
$106B
| $10.1M | 0.23% |
250,898
-17,956
| -7% | -$699K |
|
99
FedEx
FDX
$72.7B
| $9.87M | 0.23% |
59,627
-4,895
| -8% | -$850K |
|
100
Capital One
COF
$128B
| $9.81M | 0.23% |
124,517
-10,533
| -8% | -$828K |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q1 2015 Portfolio in Review
As of Q1 2015, Fjarde Ap-fonden held 629 positions worth $4.35B, down 5.7% from $4.62B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fjarde Ap-fonden withdrew a net $308M in Q1 2015, closing 10 positions and reducing 506 holdings. Its most notable exit was Allergan Inc, an estimated $15M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Fjarde Ap-fonden opened a new position in Qorvo worth $3.42M.
- Fjarde Ap-fonden's largest Q1 2015 buy was Qorvo: 42,872 shares worth $3.42M.
- Fjarde Ap-fonden added most to Allergan plc in Q1 2015, an estimated $6.19M increase.
- Fjarde Ap-fonden's biggest Q1 2015 reduction was Apple, cutting an estimated $12.4M.
- Fjarde Ap-fonden fully exited Allergan Inc in Q1 2015, selling an estimated $15M.
- Fjarde Ap-fonden's ten largest holdings make up 17% of its $4.35B portfolio in Q1 2015.
- Fjarde Ap-fonden opened 5 new positions and closed 10 in Q1 2015.
- Fjarde Ap-fonden's portfolio value fell 5.7% quarter-over-quarter to $4.35B.
Based on Fjarde Ap-fonden's 13F filing for Q1 2015, filed 13 Apr 2015.